Medication non-adherence

Digital health companies are deploying innovative solutions to help address issues with patients who fail to take their medications properly.

In this article, first published in Digital Health Legal [October 2018], Claire Smith looks at the impact of the problem, the technologies available and the key legal issues surrounding medication non-adherance.

View the PDF version of the full article.

Claire Smith

Author

LinkedIn

Credentials

Practice areas

What others say

Full profile

Back to people results

Share

Facebook

Twitter

LinkedIn

Court of Appeal considers balancing act between confidentiality and open justice

Medication non-adherence

Claire Smith

Related Articles

Court of Appeal considers balancing act between confidentiality and open justice

The AI Safety Summit and Frontier AI: regulating potentially dangerous AI

Guide to doing business in the UK

It’s not over until the Confidential Annex sings

Plausibility post G2/21 – Apixaban in the UK

The Digital Markets, Competition and Consumers Bill: Five things you need to know about the proposed changes to UK consumer law

Medication non-adherence

Claire Smith

Share

Related Articles

Court of Appeal considers balancing act between confidentiality and open justice

The AI Safety Summit and Frontier AI: regulating potentially dangerous AI

Guide to doing business in the UK

It’s not over until the Confidential Annex sings

Plausibility post G2/21 – Apixaban in the UK

The Digital Markets, Competition and Consumers Bill: Five things you need to know about the proposed changes to UK consumer law